BLP (NORTHERN) LIMITED

1. Financial Health Score: C

Explanation: BLP (Northern) Limited is displaying symptoms of significant financial stress. While the company has a healthy long-term asset base and has recently invested heavily in new equipment, its short-term liquidity is severely constrained. The business is operating with dangerously thin working capital, has become reliant on factoring (selling its invoices early) to generate cash, and has shifted from profit to loss. Like a patient with a strong skeleton but restricted blood flow, the company’s long-term health is being compromised by acute short-term cash constraints and an over-reliance on creditor financing.

2. Key Vital Signs

• Working Capital (Net Current Assets): £260,801 (Down from £650,581) Interpretation: This is the company's immediate financial immunity. A 60% drop in working capital means the business has very little buffer to cover its day-to-day obligations. With current liabilities of £4.08 million nearly matching current assets of £4.34 million, the current ratio is a fragile 1.06. This leaves no margin for error.
• Cash Reserves: £150,739 (Down from £576,409 in 2020) Interpretation: The patient’s hydration levels are low. Cash has plummeted over the last four years despite turnover likely remaining stable. The business is bleeding cash to fund its operations and capital investments.
• Debtor Factoring: £2,661,773 (Up from £1,369,670) Interpretation: This is a symptom of cash flow distress. Factoring involves selling outstanding invoices to a third party at a discount to get cash immediately. The heavy reliance on factoring—which has almost doubled—shows the company is sacrificing future margins to keep the lights on today. Furthermore, because the company still bears the credit risk on these factored debts, they remain on the balance sheet as a toxic liability if customers default.
• Inventory (Stocks): £956,211 (Up from £475,793) Interpretation: Stock levels have doubled. While this could indicate preparation for future sales, in the context of shrinking cash and a recent operating loss, it suggests potential "inventory blockages"—cash tied up in unsold goods or raw materials that are not converting into revenue quickly enough.
• Profitability: Loss of £109,553 Interpretation: The Profit and Loss reserve dropped from £1,227,980 to £1,118,427, indicating a loss for the year. The business is currently operating at a deficit, meaning it is burning through its retained reserves rather than generating new, healthy tissue.
• Hidden Liabilities (Operating Leases): £2,782,159 Interpretation: A massive off-balance-sheet tumor. The company has over £2.7 million in future lease commitments that didn't appear on the balance sheet previously. This represents a heavy future drain on cash flow.

3. Diagnosis

Acute Working Capital Anemia & Factoring Dependency

BLP (Northern) Limited is suffering from a severe mismatch between its short-term assets and short-term liabilities. The company recently undertook a major capital investment (spending £939,146 on plant and machinery), but instead of funding this through long-term debt or equity, it appears to have stretched its trade creditors (which nearly doubled to £1.98 million) and drained its cash reserves.

The business is essentially trying to run a marathon while breathing through a straw. The reliance on factoring over £2.6 million of trade debtors is a classic symptom of a business struggling to bridge the gap between paying suppliers and collecting from customers.

Compounding the diagnosis is a "blind spot" in the medical records: the auditors issued a qualified opinion because they were unable to verify the opening stock figures from 2023. If the stock is overstated, the company's net assets and working capital are even weaker than reported.

4. Recommendations

To restore financial wellness and prevent the condition from becoming terminal, the following interventions are required:

• Improve the Cash Conversion Cycle (Clear the Blockages): The doubling of inventory must be addressed. Management should implement stricter stock controls, run down excess raw materials, and potentially discount slow-moving finished goods to convert stock back into much-needed cash.
• Cure the Factoring Dependency: Factoring is an expensive form of medicine. The company must improve its credit control processes to collect cash directly from customers within standard terms, reducing the fees paid to factors and improving organic cash generation.
• Restructure the Debt (Blood Transfusion): The company has £4.08 million in current liabilities but only £3.2 million in debtors. With over £1.9 million in tangible fixed assets, the company should seek to refinance a portion of its short-term debt into long-term facilities. Moving short-term creditor pressure to long-term debt will give the business breathing room.
• Review Capital Expenditure: The heavy investment in plant and machinery must now generate the required returns. Management needs to ensure this new capacity is being fully utilized to drive profitable turnover, rather than just increasing fixed costs and depreciation.
• Address Audit Qualifications: Ensure that the 2024 year-end stock count is robust and fully documented to satisfy the auditors. The business cannot afford another qualified opinion regarding its inventory, as this damages credibility with lenders and suppliers.